Posted by Michael Wonder on 20 Jan 2022
COVID-19 vaccine weekly safety report (20 January 2022)
20 January 2022 - To 16 January 2022, the TGA has received 428 reports which have been assessed as likely to be myocarditis from about 29.7 million doses of Comirnaty (Pfizer) and 43 reports which have been assessed as likely to be myocarditis from about 2.4 million doses of Spikevax (Moderna).
No new cases of confirmed or probable thrombosis with thrombocytopenia syndrome were reported in the past week.
